ESC Premium Access

Thrombotic and hemorrhagic complications during pregnancy, delivery and the postpartum period in females with prosthetic heart valves.

Presentation

About the speaker

Ms Guinai Sefieva

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Ms G. Sefieva, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Efficacy and safety of direct oral anticoagulants in morbidly obese patients with non-valvular atrial fibrillation: a systematic review and meta-analysis

27 August 2021

ESC Premium Access

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants among nonvalvular atrial fibrillation patients with prior bleeding events

27 August 2021

ESC Premium Access

Age-adjusted risk factors are independently associated with an increased risk of ischaemic stroke, transient ischaemic stroke and systemic embolism in the ETNA-AF-Europe registry

27 August 2021

This platform is supported by

logo Novo Nordisk